Kuusisto and Page have received approval to use
de-identified electronic health records from the National VA Hospital, with approximately 10 million records, to continue the drug repurposing work, examining several drug effects such as lowering of cholesterol levels or blood pressure.
This institute will serve as a hub for the collection, analysis and distribution of biomedical and
health care information, ranging from genomic data to
de-identified electronic medical records.